Development of efficient peptide-based
immunotherapy for shrimp
allergy relies on the identification of the dominant T-cell epitopes
of its major allergen, tropomyosin. In this study, immunoinformatic
tools, T-cell proliferation, cytokine release, IgG/IgE binding, and
degranulation assays were used to identify and characterize the T-cell
epitopes in Lit v 1 in comparison with previously validated B-cell
epitopes. The results showed that of the six in silico predicted T-cell
epitopes only one (T2: VQESLLKANIQLVEK, 60–74) promoted T-cell
proliferation, the release of IL-2, and upregulated secretion of Th2-associated
cytokines in the absence of IgG/IgE binding and degranulation activities.
These findings support T2 as a candidate for the development of an
efficient peptide-based vaccine for the immunotherapy for shrimp-allergic
patients.